Visgeneer Total Liabilities
Visgeneer total liabilities. Based on the latest financial reports, Visgeneer (4197) has total liabilities worth NT$130.36 Million TWD (≈ $4.11 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Visgeneer to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Visgeneer (2011–2025)
Total liabilities of Visgeneer from 2011 to 2025. This chart illustrates how Visgeneer's total liabilities have evolved over time, based on quarterly financial data.
Visgeneer Competitors by Total Liabilities
The table below lists competitors of Visgeneer ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PRS Reit PLC
LSE:PRSR
|
UK | GBX442.94 Million |
|
Adelong Gold Ltd
AU:ADG
|
Australia | AU$702.45K |
|
Muza S.A
WAR:MZA
|
Poland | zł18.80 Million |
|
DXN Ltd
AU:DXN
|
Australia | AU$10.91 Million |
|
WALKER RIVER RES CORP
F:1WV0
|
Germany | €562.04K |
|
Axolot Solutions Holding AB
ST:AXOLOT
|
Sweden | Skr4.00 Million |
|
Ekiz Kimya Sanayi ve Ticaret AS
IS:EKIZ
|
Turkey | TL37.32 Million |
|
CYL Corporation Bhd
KLSE:7157
|
Malaysia | RM19.44 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Visgeneer's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4197 current and non-current assets.
Liquidity & Leverage Metrics
Visgeneer Total Liabilities Ratios Explained
Visgeneer total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Visgeneer's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Visgeneer (2011–2025)
The table below shows the annual total liabilities of Visgeneer from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$135.94 Million ≈ $4.28 Million |
-1.67% |
| 2024-12-31 | NT$138.25 Million ≈ $4.36 Million |
-25.51% |
| 2023-12-31 | NT$185.60 Million ≈ $5.85 Million |
-27.38% |
| 2022-12-31 | NT$255.58 Million ≈ $8.05 Million |
+22.74% |
| 2021-12-31 | NT$208.23 Million ≈ $6.56 Million |
-14.65% |
| 2020-12-31 | NT$243.97 Million ≈ $7.69 Million |
-7.37% |
| 2019-12-31 | NT$263.37 Million ≈ $8.30 Million |
+30.32% |
| 2018-12-31 | NT$202.09 Million ≈ $6.37 Million |
-24.20% |
| 2017-12-31 | NT$266.61 Million ≈ $8.40 Million |
+28.32% |
| 2016-12-31 | NT$207.76 Million ≈ $6.55 Million |
-7.10% |
| 2015-12-31 | NT$223.64 Million ≈ $7.05 Million |
+218.59% |
| 2014-12-31 | NT$70.20 Million ≈ $2.21 Million |
+50.02% |
| 2013-12-31 | NT$46.79 Million ≈ $1.47 Million |
+45.00% |
| 2012-12-31 | NT$32.27 Million ≈ $1.02 Million |
+21.13% |
| 2011-12-31 | NT$26.64 Million ≈ $839.34K |
-- |
About Visgeneer
Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; f… Read more